课题基金 / 基金详情

Monoclonal antibodies targeting plasma cells as novel therapeutic agents and diagnostic tools

Monoclonal antibodies targeting plasma cells as novel therapeutic agents and diagnostic tools
靶向浆细胞的单克隆抗体作为新型治疗剂和诊断工具
批准号:
nhmrc : 575575
负责人:
Prof David Tarlinton
金额:
$13.29万
依托单位国家:
澳大利亚
项目类别:
NHMRC Development Grants
财政年份:
2009
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2009-01-01 至 2009-12-31

项目摘要

项目成果

Prof David Tarlinton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have a new tool to identify a very rare immune cell type. This cell makes antibodies, powerful and exquisitely specific proteins that fight infection. In health, antibody-producing cells are beneficial, but in disease (rheumatoid arthritis, lupus and myeloma), these cells cause disease or death. Antibody-producing cells are long-lived. We have no means to specifically deplete them. We are developing reagents to identify and deplete antibody-producing cells to use as novel therapeutic agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the Immune Response
  • 批准号:
    nhmrc : GNT1054925
  • 项目类别:
    Programs
  • 资助金额:
    $903.06万
  • 财政年份:
    2014
  • 负责人:
    Prof David Tarlinton
  • 依托单位:
A Systems Approach to the Adaptive Immune Response
Understanding antibody responses
  • 批准号:
    nhmrc : GNT1060675
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $72.76万
  • 财政年份:
    2014
  • 负责人:
    Prof David Tarlinton
  • 依托单位:
The regulation of B cell differentiation and survival in response to antigen challenge
  • 批准号:
    nhmrc : 1060675
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $50.9万
  • 财政年份:
    2014
  • 负责人:
    Prof David Tarlinton
  • 依托单位:
海外基金